Cargando…
Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom
Irritable bowel syndrome with constipation (IBS-C) as the predominant bowel symptom is a prevalent disorder, characterized by recurring abdominal pain/discomfort, bloating, and constipation, and imposes a significant socio-economic burden. Traditional treatments generally address just one of the mul...
Autores principales: | Layer, Peter, Keller, Jutta, Loeffler, Helena, Kreiss, Andreas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936292/ https://www.ncbi.nlm.nih.gov/pubmed/18360619 |
Ejemplares similares
-
The Effect of Tegaserod on Symptoms and Quality of Life in Korean Women with Irritable Bowel Syndrome with Constipation
por: Kim, Yong Sung, et al.
Publicado: (2010) -
Tegaserod for the Treatment of Irritable Bowel Syndrome
por: Madia, Valentina Noemi, et al.
Publicado: (2020) -
Comments on Tegaserod Trial on Irritable Bowel Syndrome
por: Jung, Hye-Kyung
Publicado: (2010) -
Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials
por: Shah, Eric D., et al.
Publicado: (2021) -
Review article: linaclotide for the management of irritable bowel syndrome with constipation
por: Layer, P, et al.
Publicado: (2014)